Midostaurin approved to treat AML, SM in EuropeSeptember 21, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
FDA grants RMAT designation to HSCT adjunctSeptember 21, 2017AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLALLMyelodysplastic Syndrome
Team creates guidelines on CAR T-cell-related toxicitySeptember 20, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLNon-Hodgkin LymphomaAggressive Lymphomas
Antibody shows early promise in AML/MDS trialSeptember 20, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Trials of atezolizumab placed on partial holdSeptember 19, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends approval of generic imatinibSeptember 18, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
CHMP advocates refusal of application for SM drugSeptember 18, 2017Leukemia, Myelodysplasia, TransplantationPharmacy
Application for pegfilgrastim biosimilar withdrawnSeptember 17, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
CHMP recommends approval of nilotinib for kidsSeptember 16, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML